Cite
HARVARD Citation
Karimi Fard, M. et al. (2019). Alendronate improves fasting plasma glucose and insulin sensitivity, and decreases insulin resistance in prediabetic osteopenic postmenopausal women: A randomized triple‐blind clinical trial. Journal of diabetes investigation. 10 (3), pp. 731-737. [Online].